FORCE Blog

This blog will cover topics of interest that affect our community. Unless otherwise stated, the blog articles will be written by Sue Friedman, Executive Director of FORCE.

| More

Posts Tagged ‘cancer research’

November 19, 2019

FORCE Launches the New XRAY-Ovarian Cancer Program

by Teri Woodhull I am so excited for a new FORCE program called XRAY-Behind the Ovarian Cancer Headlines! My ovarian cancer was already advanced by the time it was diagnosed and I believe that research has played a big role in my nine-year survival. Admittedly, I’m a bit of a research junkie. I attend scientific … + read more

May 1, 2019

Where’s FORCE?

This issue of “Where’s FORCE?” features an overview of the many events in which FORCE staff and volunteers participated during the past few months. December December is often a slow time due to the holidays, but the FORCE team kept busy. Our research team—Executive Director Sue Friedman, Vice President of Education Piri Welcsh, and Director … + read more

January 31, 2019

Highlights from the 2018 Joining FORCEs Conference

Our Joining FORCEs conference informs, inspires and supports the hereditary cancer community. Judging from the feedback, last year’s October conference (our 11th!) once again successfully hit the mark. More than 700 people from the U.S. and other countries traveled to San Diego looking for more answers, deeper understanding, a stronger sense of community, clarity on … + read more

November 3, 2018

XRAYS Blog: Sharsheret Webinar Helps People Make Sense of Breaking News in Breast and Ovarian Cancer

by Elaine Gottesman Sharsheret is one of the partner organization for FORCE’s XRAYS Program. Sharsheret’s webinar, “Breaking News In Breast And Ovarian Cancer And What Should I Make Of It?” recapped some of the key takeaways from the 2018 American Society of Clinical Oncology’s Annual Meeting. Featuring Dr. Deanna Attai, of UCLA Health Burbank Breast … + read more

August 27, 2018

FORCE Co-Authors Paper on Engaging Patient Advocates in Research

by Lisa Schlager A year ago, I wrote a blog titled “Working with Industry to Increase Patient Engagement in Drug Development.”  In it, I shared that FORCE is a member of Bayer Pharmaceutical’s 5-member Patient Advocacy Advisory Council (PAAC), a novel partnership between this leading drug developer and the patient advocate community. From late 2016 … + read more

April 12, 2018

PARP Inhibitors and Hereditary Cancer: What’s New?

by Sue Friedman PARP inhibitors are drugs designed specifically to treat cancers in people with certain inherited mutations, including BRCA1 and BRCA2, among others. These drugs block an enzyme – known as PARP – used by cells to repair damage to their DNA. Although these agents seem to be most effective in people with mutations—not just … + read more

February 7, 2018

Why I Chose Immunotherapy for Pancreatic Cancer

by David Dessert I was diagnosed with stage 3 unresectable pancreatic cancer at age 48 after 5 months of ever-increasing back and abdominal pains. After a non-standard treatment with Gemzar/Cisplatin chemotherapy (because of my BRCA2 mutations), followed by chemoradiation, and 12 months later the removal of my pancreatic tumor, my surgeon told me that I … + read more

August 17, 2017

Working with Industry to Increase Patient Engagement in Drug Development

by Lisa Schlager Historically, the only role for patients in cancer research was as a subject enrolled in a clinical trial. Research generally focused exclusively on outcomes such as overall survival and neglected to account for variables such as side effects and quality of life. Engaging patients as advisors in research—reviewing study design, informed consent … + read more

Connect with others.

Call our Helpline

Our helpline offers peer support for people concerned about hereditary cancer. All calls are confidential. Call any time.

Join a Local Group

FORCE has outreach groups throughout the United States and in Essex, United Kingdom that meet periodically to offer peer support, and share resources.

FORCE:Facing Our Risk of Cancer Empowered